XML 25 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Income Taxes
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
Note
7.
  Income Taxes
 
The following table summarizes the income tax (expense) benefit for the years ended
December 31, 2020
and
2019
(in thousands):
 
    2020   2019
Current:                
Federal   $
-
    $
-
 
State    
(36
)    
(30
)
Foreign    
(142
)    
(276
)
Current Total    
(178
)    
(306
)
Deferred:                
Federal    
(633
)    
(36
)
State    
(91
)    
(58
)
Foreign    
-
     
-
 
Deferred Total    
(724
)    
(94
)
Total   $
(902
)   $
(400
)
 
The income tax expense differs from the amount computed by applying the statutory federal and state income tax rates to the net income before income tax.  The following table shows the reasons for these differences (in thousands):
 
    2020   2019
Computed income tax benefit at statutory rate   $
789
    $
944
 
Increase in taxes resulting from:                
Permanent and other deductions, net    
51
     
(55
)
Goodwill impairment    
(120
)    
(727
)
Global intangible low-taxed income    
(113
)    
(200
)
Foreign income taxes    
10
     
-
 
State income taxes, net of federal benefit    
120
     
(9
)
Deferred tax effects    
(153
)    
(13
)
Valuation allowance    
(1,486
)    
(340
)
Total income tax expense   $
(902
)   $
(400
)
Effective tax rate    
22.3
%    
9.1
%
 
The Company reported income tax expense of
$0.9
million for
2020
despite a pre-tax loss. The expense was primarily due to a
$1.5
million valuation allowance recorded against deferred tax assets. The valuation allowance was the result of management's assessment as of
December 31, 2020
that it was
not
more likely than
not
that the benefit of the Company's deferred tax assets would be realized primarily due to the impact of the COVID-
19
pandemic on its business. Income tax expense for
2020
was also impacted by foreign taxes in the United Kingdom related to the Company's London office that are
not
deductible for U.S. income tax purposes. In addition, the
$0.8
million goodwill impairment recorded in
2020
resulted in only a
$0.1
million tax benefit due to certain permanent tax differences.
 
The Company reported income tax expense of
$0.4
million for
2019
despite a pre-tax loss due primarily to a
$0.3
million valuation allowance recorded against deferred tax assets related to forfeited stock options. Income tax expense for
2019
was also impacted by foreign taxes in the United Kingdom related to the Company's London office that are
not
deductible for U.S. income tax purposes. In addition, the
$4.8
million goodwill impairment recorded in
2019
resulted in only a
$0.3
million tax benefit due to certain permanent tax differences.
 
The following table shows the tax effect of significant temporary differences, which comprise the deferred tax asset and liability (in thousands):
 
    2020   2019
Deferred tax asset:                
Net operating loss carryforward   $
1,063
    $
103
 
Foreign tax credits    
483
     
483
 
Accrued expenses    
396
     
549
 
Allowance for doubtful accounts    
78
     
85
 
Lease liability    
146
     
422
 
Share-based compensation    
49
     
384
 
Other intangible assets    
30
     
36
 
Interest expense limitation    
23
     
11
 
Less: Valuation allowance    
(1,486
)    
(340
)
Total deferred income tax asset    
782
     
1,733
 
Deferred tax liability:                
Property and equipment    
(159
)    
(393
)
Right of use asset    
(136
)    
(391
)
Intangible assets-brand name    
(1,197
)    
(1,079
)
Goodwill    
(288
)    
(257
)
Other intangible assets    
(451
)    
(338
)
Total deferred income tax liability    
(2,231
)    
(2,458
)
Net deferred tax liability   $
(1,449
)   $
(725
)
 
The presentation of net deferred tax assets and liabilities are presented as noncurrent within the Company's Consolidated Balance Sheets. Deferred income tax balances reflect the effects of temporary differences between the carrying amounts of assets and liabilities and their tax bases and are stated at enacted tax rates expected to be in effect when the taxes are actually paid or recovered. The Company recognizes a valuation allowance for deferred tax assets when it is more likely than
not
that these assets will
not
be realized. In making this determination, all positive and negative evidence is considered, including future reversals of existing taxable temporary differences, tax planning strategies, future taxable income, and taxable income in prior carryback years.
 
At
December 31, 2020
and
December 31, 2019,
the Company has
$4.3
million and
$0.5
million, respectively, of federal net operating loss carryforwards, of which
$0.5
million expires in
2037
and the remainder do
not
expire. Additionally, the Company has
$0.5
million of U.S. federal foreign tax credit carryforwards, which expire between
2023
and
2029.
 
The Company does
not
believe that it had any significant uncertain tax positions at
December 31, 2020
and
December 31, 2019,
nor is this expected to change within the next
twelve
months due to the settlement and expiration of statutes of limitation.
 
The U.S. Tax Cuts and Jobs Act (the “Tax Act”) was enacted on
December 22, 2017
and introduced significant changes to U.S. income tax law. Effective in
2018,
the Tax Act reduced the U.S. statutory tax rate from
35%
to
21%
and created new taxes on certain foreign-sourced earnings and certain related-party payments, which are referred to as the global intangible low-taxed income tax and base erosion tax, respectively. In
January 2018,
the FASB released guidance on the accounting for tax on the global intangible low-taxed income (“GILTI”) provisions of the Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. The Company elected to treat any potential GILTI inclusions as a period cost.